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HIC-5 is a multidomain LIM protein homologous to paxillin that serves as a molecular scaﬀold at focal adhesions and in the
nucleus. It forms mobile molecular units with LIM-only proteins, PINCH, and CRP2 and translocates in and out of the nucleus
via a nuclear export signal (NES). Of note, NES of HIC-5 is distinctive in its sensitivity to the cellular redox state. Recently, the
mobile units of HIC-5 have been suggested to be involved in the regulation of the anchorage dependence of cell growth. On loss
of adhesion, an increase in reactive oxygen species in the cells modiﬁes NES and stops shuttling, which leads to cell-cycle control.
More speciﬁcally, the system circumvents nuclear localization of cyclin D1 and transactivates p21Cip1 in detached cells, thereby
avoiding anchorage-independent cell growth. Thus, the HIC-5-LIM only protein complex has emerged as a fail-safe system for
regulating the anchorage dependence of cell growth.
1.Introduction
Hydrogen peroxide-inducible clone 5 or Hic-5 is a gene we
isolated by subtractive hybridization in 1994 as a cDNA
clone induced by transforming growth factor β (TGF-β)
or hydrogen peroxide [1]. At that time, we studied TGF-β
signalling and pursued the possibility that reactive oxygen
species (ROS) function was an intracellular TGF-β signal.
After isolating the gene, we conducted a number of studies
of Hic-5 at a molecular as well as cellular level. Its amino
acidsequencerevealedthatHIC-5isahomologueofpaxillin,
which is a multidomain LIM (Lin-11, Isl-1, and Mec-3)
protein that is localized at focal adhesions and was originally
identiﬁed as a substrate of the v-src oncogene [2]( Figure 1).
Together with its family members (Leupaxin speciﬁcally
expressed in lymphocytes, PaxB, an orthologue of paxillin in
slime mold, and HIC-5), paxillin has now been established
as a molecular adaptor that transduces signals in response
to changes in the adhesion environment of cells. A famous
example of a molecular adaptor is the Grb2-SOS system
that transduces signals from growth factor receptors to
RAS. Paxillin transduces signals from extracellular matrix
receptors, integrins, to intracellular downstream molecules
such as MAP kinase.
Of these family members, HIC-5 is most homologous to
paxillin, and thus, analyses of HIC-5 have been conducted in
reference to and in comparison with paxillin. For example,
the intracellular localization of HIC-5 is, like paxillin,
mainly conﬁned to so-called focal adhesion sites where cells
adhere to the extracellular matrix via integrins. In terms
of expression in tissues and cell types, paxillin is relatively
ubiquitously expressed, whereas expression of HIC-5 is
prominent in the smooth muscle layer of tissues such as the
large intestine and uterus [3]. Furthermore, expression of
HIC-5 is relatively high in the lung and spleen [1]. In cell
culture systems, HIC-5 expression is detectable in most cell
lines with varying degrees of expression. High expression of
HIC-5isdetectedinmesenchymalcelllinesincludingﬁbrob-
lasticandosteoblasticcelllines;however,itisgenerallylowin
epithelial cell lines. In a knockout mouse model, HIC-5 was
suggested to be inessential for the development and main-
tenance of homeostasis of the animal, and no remarkable
functional abnormality was found under standard rearing2 International Journal of Cell Biology
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Figure 1: The paxillin/focal adhesion-associated adaptor protein family; domain structure and binding factors. The paxillin family includes
HIC-5, Leupaxin, which is preferentially expressed in hematopoietic cells, and PaxB, an orthologue of paxillin in the slime mould
Dictyostellium discoidium. The family members share many of their structural characteristics and binding factors. They have four to ﬁve
leucine-rich motifs (LD repeats) in the N-terminal half and four cysteine-rich regions composed of two zinc ﬁngers (LIM domains) in the
C-terminal half. These domains mediate the protein-protein interactions that allow paxillin to bind a variety of structural and signalling
molecules, such as the structural protein vinculin, the SH2-SH3 adaptor protein Crk, Src, focal adhesion kinase (FAK), PTK2B protein
tyrosine kinase 2 beta (PYK2), a negative regulator of Src, the Csk nonreceptor tyrosine kinase, the G protein-coupled receptor kinase
interactor Arf GAP1 (GIT-1), paxillin-kinase linker (PKL), protein tyrosine phosphatase-PEST (PTP-PEST), and heat shock protein 27
(HSP27). The LIM domains also mediate the localization of Hic-5 at the nucleus and at focal adhesions. HIC-5 has the same binding
partners, except for Crk and Src, as paxillin.
conditions [4]. In contrast, the paxillin knockout mouse is
reportedly embryonic lethal [5]. Similar to ﬁbronectin, it
exhibits abnormal development of extraembryonic tissues
and heart and body segmentation, resulting in death at 9.5
foetal days. The embryonic lethality of the paxillin knockout
mouse means that HIC-5 cannot substitute the functions of
paxillin, at least those associated with development. These
results together with the abovementioned diﬀerences in
expression patterns indicate that it is most likely that paxillin
and HIC-5 have diﬀerent functions in mammals.
2.StructureofHIC-5andInteractingFactors
The genomic structure of Hic-5 features a long intron
between the N-terminal and C-terminal domains, a sign
that Hic-5 evolved from the fusion of two diﬀerent genes
[6]. Accordingly, the protein structure can also be broadly
divided from the centre into N-terminal and C-terminal
regions.
The N-terminal region comprises four domains, the LD
domains, which are rich in Leu and Asp; LD1 is deleted
in one isoform. The C-terminal region comprises four
LIM domains having two zinc ﬁngers (Figure 1). These
features are almost identical to those of paxillin, with
minor diﬀerences in the number of LD domains in the N-
terminal region (ﬁve for paxillin and four for HIC-5). Given
that both the LD and LIM domains are protein-protein
interacting domains, it is naturally assumed that paxillin
family members are adaptor molecules that provide multiple
proteins with interfaces to facilitate their interaction and
cooperation.
Based on these structural features, further analyses have
successfully identiﬁed a number of interacting factors. In
particular, in the case of adaptor molecules, identiﬁcationInternational Journal of Cell Biology 3
of their interacting factors is crucial for inferring their
functions. Several interacting factors of paxillin have been
identiﬁed previously. Therefore, we began to study their
interaction with HIC-5. Isolation of new interacting factors
was also attempted, and we found an array of proteins that
interact with each of the LD and LIM domains of HIC-5 [2]
(Figure 1). Consistent with the localization of HIC-5 at focal
adhesions, most of the factors identiﬁed are those contained
in the cytoplasmic domain complex of integrins (discussed
below) and are involved in integrin signal transduction
and/or in the control of actin cytoskeleton dynamics. More
speciﬁcally, the factors include signalling molecules such as
protein tyrosine kinase 2 beta (PYK2), c-src tyrosine kinase
(Csk), and focal adhesion kinase (FAK) [7, 8]. Using a yeast
two-hybrid method with the N-terminal and C-terminal
domains of HIC-5 as bait, we originally characterized G
protein-coupled receptor kinase interacting Arf GAP1 (GIT-
1) as an LD3 interacting factor [9] and protein tyrosine
phosphatase, nonreceptor type 12 (PTP-PEST) as an LIM3
interacting factor [10]. Vinculin and talin are structural
proteins involved in the architecture of focal adhesions and
theactincytoskeleton,andthesealsointeractwithHIC-5[8].
Most of the factors that bind to HIC-5 also interact with
paxillin although paxillin additionally binds Src and Crk (v-
crk sarcoma virus CT10 oncogene homologue), which do
not bind to HIC-5 [2, 8]. Accordingly, HIC-5 and paxillin
hypothetically compete for these interacting factors. This
diﬀerence is presumably because of the presence of tyrosine
residues (Y31, Y118, Y188, and Y190) in paxillin, which do
not exist in HIC-5 although no deﬁnitive answer has been
obtained yet. Furthermore, it is known that paxillin binds
the cytoplasmic domains of α4, α9, and β3 integrins [11],
and HIC-5 interacts with the domain of α4. No particular
pattern of interaction has been identiﬁed for the LD and
LIM domains of HIC-5 and paxillin and their corresponding
interacting factors. Thus, the study as above identiﬁed only
factors whose localization and functions are related to focal
adhesions. Furthermore, no factors that interact speciﬁcally
with HIC-5 were identiﬁed.
HIC-5 has also been found to be localized in actin stress
ﬁbers, while paxillin is not [3]. Here, HIC-5 appeared to
interactwithcysteine-richprotein(CRP)2,whichbelongsto
the LIM-only group of proteins [3]. This ﬁnding prompted
us to search for other LIM-only proteins that interact with
HIC-5, and we identiﬁed a particularly interesting new
cysteineandhistidine-richprotein(PINCH)thatbindsHIC-
5[ 12]. Further investigation demonstrated that LIM4 in
the C-terminal is important for HIC-5 interaction with
these LIM-only proteins. In other words, the fourth LIM
domain located at the endmost C-terminal region has a
unique property, whereby it interacts with the same LIM
domain, thus enabling HIC-5 to form LIM-LIM homo-
and hetero-oligomers [12]. Consequently, HIC-5 exists as
homo-oligomers in cells, which appear to be important
for HIC-5 localization in the nuclear matrix (unpub-
lished data). Hetero-oligomer formation between HIC-5 and
PINCH/CRP2 is essential for the two LIM-only proteins
to localize at particular sites in cells [12]. This means that
HIC-5 directs their subcellular localization (as discussed
below). It should be noted that LIM4 of paxillin cannot
form oligomers and does not interact with PINCH or
CRP2. This diﬀerence is surprising given the high structural
homology between HIC-5 and paxillin. Another molecular
diﬀerence is that paxillin is highly tyrosine-phosphorylated
duringadhesionandgrowthsignalling,whereasHIC-5isnot
generally tyrosine-phosphorylated to a signiﬁcant level. This
might be explained by the fact that HIC-5 has no tyrosine
residues per se to be phosphorylated [13]. Thus, unlike
paxillin, HIC-5 appears to not have a function in adhesion
and growth signalling based on tyrosine phosphorylation
although in human platelets, HIC-5 has been shown to be
tyrosine-phosphorylated with aggregation.
Studies at a molecular level have characterized paxillin
and HIC-5 as being tyrosine-phosphorylated and forming
LIM-LIM oligomers, respectively, which possibly underlies
the functional diﬀerence between them. Paxillin may trans-
duce adhesion/growth signalling, and HIC-5 organizes a fail-
safe system for the adhesion dependence of cell growth, as
discussed below.
3 .F unc tio nso fHIC-5atF oc alA d h e sio nsand
inthe Nucleus
Adhesion between cells and the extracellular matrix is
achieved by integrins, a group of transmembrane proteins
that act as receptors for the extracellular matrix. The
resultantadhesionofcellstotheextracellularmatrix,inturn,
promotes aggregation between integrins, resulting in the
formation of a protein complex known as a focal adhesion
at the site of adhesion. Importantly, a focal adhesion is not
just a physical structure but also a molecular apparatus that
senses the adhesion status between cells and the extracellular
matrix and sends signals to the inside of cells, thereby
coordinating their motility, survival, and proliferation in
response to adhesion status [14, 15]. During signalling
by integrins whose cytoplasmic domain is very short and
contains no enzymatic catalytic domain, multiple proteins
assembleatthecytoplasmicdomainthroughprotein-protein
interactions, forming an undercoat structure. These proteins
include several enzymes such as FAK and SRC, through
which the signal is emitted to the inside of the cell [14, 15].
HIC-5 and paxillin act as adaptor molecules in this
integrin undercoat complex and play roles in controlling
enzyme activity by mediating the above-mentioned inter-
actions between binding factors, thereby participating in
the regulation of integrin signalling. A detailed study has
shown that HIC-5 plays a role in negatively regulating FAK
by competing with paxillin [16]. However, under normal
culture conditions, cellular behaviours including growth and
motility are hardly aﬀected by HIC-5 expression in most
cases. Therefore, HIC-5 appears to not be required for any
particular function at focal adhesions under normal cellular
conditions so long as the adhesion status is maintained.
Normal phenotype observed in the knockout mice strongly
supports this idea. Rather, HIC-5 may have a critical
function in suppressing excess changes in adhesion and
the cytoskeleton structure by antagonizing paxillin when
the maintenance of healthy adhesion is in jeopardy under4 International Journal of Cell Biology
stressful conditions aﬀecting adhesion [3, 16]. In sharp
contrast, abnormal cell motility and spreading is observed
under normal conditions in paxillin−/− cells in which the
focal adhesions are disorganized and integrin signalling by
FAK and the downstream MAP kinase is disturbed [5].
In parallel with localization at focal adhesions, HIC-
5 simultaneously shuttles between focal adhesions and the
nucleus, as described below. This fact lead us to investigate
the possible function of HIC-5 in the nucleus, and a
series of study demonstrated that HIC-5 was capable of
regulating expression of the c-fos and p21Cip1 genes [17, 18].
This involvement in transcription was not observed with
paxillin. Further study demonstrated that HIC-5 promotes
the formation of a transcriptional complex, speciﬁcally
with the transcriptional coactivator p300 and transcription
factors Sp1 and Smad3, on DNA [18]. In other words,
HIC-5 appears to function as an adaptor for transcription-
associated factors in the nucleus by acting as a scaﬀold for
transcriptional complex formation, as is the case for integrin
signalling at focal adhesions. A similar function of HIC-5
in the nucleus has been suggested by other researchers who
recloned HIC-5 as an androgen receptor coactivator 55kDa
protein (ARA55), in 1999 [19, 20]. It has also been reported
that HIC-5/ARA55 is a coactivator of PPARγ and others
[21, 22]. Taken together, these results indicate that HIC-
5/ARA55 may serve as a scaﬀold for a fairly wide range of
transcriptional activities in the nucleus.
In summary, a growing body of evidence suggests
that the function of HIC-5 in the nucleus is to facilitate
transcription complex formation by interactions with sev-
eral transcription-associated factors. However, taking into
consideration the fact that under normal conditions, HIC-
5 is mainly localized at focal adhesions and not in the
nucleus at a detectable level, we should be cautious about
this conclusion. Rather, we postulate that HIC-5 has some
roles in the nucleus, primarily under conditions where focal
adhesionshavebeendisruptedandthatlocalizationofHIC-5
in the nucleus then becomes discernable.
4. Nuclear-CytoplasmicShuttlingof
HIC-5andIts Biological Signiﬁcance:
A Fail-Safe System for Anchorage
Dependence of Cell Proliferation
In 2003, we found that HIC-5 shuttles between focal adhe-
sionsandthenucleus[23].Ourinitialobservationsindicated
that HIC-5 changed its localization to the nucleus following
treatment with hydrogen peroxide, suggesting that besides
focal adhesions, HIC-5 can also localize in the nucleus based
on the cellular conditions. Finally, we found that HIC-5
shuttles between focal adhesions and the nucleus constantly
in normal adhesion cells and that it does so in company with
PINCH and CRP2, its LIM-LIM hetero-oligomer partners.
This molecular-level analysis of the shuttling ability of
HIC-5 identiﬁed NES around the LD3 domain [23]. A
nuclear localization signal is carried by four LIM domains
in the C-terminal region. Of note, there are speciﬁc cysteine
residues upstream of the NES consensus sequence in HIC-5
thatenableNEStosensetheintracellularredoxstate.Because
of this, NES is interrupted to stop the export of HIC-
5 from the nucleus under conditions such as hydrogen
peroxide treatment, which results in the accumulation of the
protein in the nucleus [23]. In short, HIC-5 shuttles between
focal adhesions and the nucleus in normal situations, but it
accumulatesandbecomesfunctionalinthenucleuswhenthe
intracellular redox state becomes more oxidised. Of interest,
when cells are deprived of adhesion to a substrate, the ROS
concentration in the cells increases [24].
These ﬁndings indicate that HIC-5 is a shuttle protein
and an ROS eﬀector, just as the name suggests. Most
ROS eﬀectors are signalling molecules centred on tyrosine
phosphatase or transcription factors. HIC-5 is probably the
ﬁrst ROS eﬀector to act as an adaptor. In addition, HIC-
5 is unique in that it uses ROS as a switch for changing
its localization by sensing ROS in NES. A group of LIM
proteins including paxillin, zyxin, LLP, and a thyroid hor-
mone receptor-binding factor, Trip 6, has also been shown
to communicate between focal adhesions and the nucleus
although the controlling mechanisms and signiﬁcance of this
shuttling are poorly understood [25].
Next, we explored the signiﬁcance of the shuttling of
HIC-5 between the two compartments. Hypothetically, by
shuttling, HIC-5 connects the adhesion status with nuclear
activity. We focused on the adhesion (anchorage) depen-
dence of cell proliferation as an example of a phenomenon
that requires such a coupling mechanism.
Numerous studies have deﬁned the roles of adhesion sig-
nals mediated by integrin-extracellular matrix (ECM) inter-
action in cell-cycle progression, Basically, integrin-ECM-
mediated signaling potentiates and prolongs the growth fac-
tor receptor-mediated mitogenic signalling and is required
from mid- to late-G1 phase in various events associated
with cell-cycle progression, such as upregulation of G1-
phase cyclin-dependent kinase (CDK) activity, Cip/Kips
downregulation, association of cyclin E with CDK2, pRB
phosphorylation, and cyclin A expression. As a result, loss
of adhesion generally causes complete G1 phase cell-cycle
arrestinnontransformedcells;moreover,insusceptiblecells,
it leads to anoikis, a speciﬁc type of apoptosis caused by the
detachment of a cell from its supportive matrix, which was
ﬁrst described in epithelial and endothelial cells [26, 27]. In
contrast, transformed cells usually circumvent the anchorage
requirement in cell-cycle progression. Their anchorage-
independentsurvivalandgrowthiswellknownasahallmark
ofcellulartransformationandcorrelateswithtumorigenicity
in vivo. Mechanistically, the anchorage-independent growth
is considered to be based on an abnormal activation of
the G1-phase cyclin CDKs uncoupled from anchorage. In
general, an oncogenic pathway activates a robust and/or con-
stitutive mitogenic signal, which is presumed to reduce the
requirement for integrin-ECM-mediated signalling and its
importance as a booster of growth factor receptor-mediated
mitogenic signalling in the transformed cells. Among the
downstream pathways of oncogenic signals, the activation
of the phosphatidylinositol 3-kinase/Akt pathway is crucial
for the induction of anchorage-independent growth and cell
survival.International Journal of Cell Biology 5
Among the events required for the cell-cycle progression,
activation of CDK4/6 by cyclin D is one of the most
important events, because it promotes the G1/S transition;
that is, it serves as a determinant of cell-cycle progression
along with cyclin E/CDK2 activity. Importantly, activation
of this complex is sensitive to adhesion status as well as
growth stimuli, and it plays a role in coupling adhesion
status with cell-cycle progression. Thus, under conditions
of inappropriate adhesion, it operates by circumventing
progression of the cell cycle. In other words, besides acting
as an engine of cell-cycle progression, CDK4/6-cyclin D
functions as a security system for the anchorage dependence
of cell proliferation. Mechanistically, the expression level of
cyclin D is regulated not only by growth signals but also by
adhesion signals, and an insuﬃciency of either signal type
decreases its expression [28, 29]. The level of expression of
other cyclins rather automatically cycles up and down with
progression of the cell cycle, as their name suggests. Thus,
Cyclin D is a key molecule in regulation of the cell cycle, and
abnormal cyclin D behaviour is directly linked to aberrant
proliferation of cells, which is supported by the fact that
c y c l i nDi sap r o t o - o n c o g e n e .
Accordingly, not only the amount of cyclin D in cells
but also its subcellular localization is rigorously regulated
by signalling, and cyclin D localizes in the nucleus only
during G1/S phase, when nuclear localization is essential
for its function; it is exported from the nucleus during the
other phases [30] .W h e nt h i sd o e sn o to c c u r ,i tb e c o m e s
oncogenic, as has been shown by observations, where the
nuclear localization of cyclin D promoted cell proliferation;
its oncogenic potential is closely related to its nuclear local-
ization ability [31]. Regulation of the nuclear localization of
cyclin D is so important that we hypothesized that it may
also be regulated by adhesion status. Therefore, we examined
the relationship between the nuclear localization of cyclin
D1 and the adhesion status of cells. In adherent cells at
G1 phase, cyclin D1 is localized in the nucleus. However,
this localization changes immediately to the cytoplasm when
cells are suspended [24]. This result supports the above
hypothesis that the nuclear localization of cyclin D1 is also
regulated by the adhesion status. This regulation would be
of great help in avoiding unacceptable cell growth when cells
are detached; most interestingly, HIC-5 is deeply involved in
this mechanism. Basically, HIC-5 and cyclin D1 translocate
between the cytoplasm and nucleus through the same CRM
1-dependent nuclear export system, and for this reason, they
compete for this export system. The presence of PINCH with
HIC-5 is important for the competition between HIC-5 and
cyclin D1. A critical step is that HIC-5 stops shuttling in cells
onlossofadhesion,theconsequenceofwhichistheexportof
cyclinD1 in placeof HIC-5outside thenucleus. Thearrestof
shuttling in nonadherent cells is caused by an elevated level
of ROS, which inactivates NES [24].
To summarize, the biological signiﬁcance of the shut-
tling of HIC-5 is competitive localization of cyclin D1
in the nucleus in adherent cells with the aid of PINCH.
Importantly, the shuttling of HIC-5 is in the oﬀ state in
nonadherent cells. This results in critical acceleration of the
export of cyclin D1 to the cytoplasm and in the arrest of cell
proliferation under abnormal conditions. This mechanism,
w h i c hi sr e g u l a t e db yt h eo n / o ﬀ status of HIC-5 shuttling,
functions as a fail-safe system for ensuring the anchorage
dependence of cell proliferation (Figure 2).
Mostrecently,wefoundanadditionalmechanisminvolv-
ing HIC-5 for inducing growth arrest in detached cells.
The mechanism targets p21Cip1, a cyclin-dependent kinase
inhibitor that is famous as the downstream target of the
tumour-suppressor gene p53. This gene is well known to be
transactivated by p53 in response to a variety of stresses and
tostopG1/SprogressionbyinhibitionofcyclinD-CDK4/6or
cyclin E-CDK2. Of note, when cells are deprived of adhesion,
p21Cip1 is upregulated and plays a critical role in growth
arrest [29]. Our recent investigation suggests that HIC-5
participates in the transactivation of p21Cip1 in response to
loss of anchorage. In this case, HIC-5 cooperates with CRP2,
another LIM-only protein shuttling partner, to transactivate
theKLF4andRunx1sitesupstreamofthegene(unpublished
data).
In conclusion, HIC-5 has emerged as a critically impor-
tant molecule for regulation of the anchorage dependence
of cell proliferation. More speciﬁcally, HIC-5 organizes
two types of mobile LIM-LIM oligomer platforms with
PINCH and CRP2, which collaboratively prevent anchorage-
independent cell growth. For this purpose, HIC-5/PINCH
regulates the nuclear localization of cyclin D and HIC-
5/CRP2 is operational in the transactivation of p21Cip1
(Figure 3).
5. Adhesion Statusof Cells and HIC-5
Aseriesofstudiesbyusandothershavesuggestedinteresting
possibilities for the function of HIC-5 at focal adhesions
and in the nucleus. We also have originally addressed its
role as a mobile scaﬀold for the anchorage dependence of
cell growth. However, in terms of an active role of HIC-5
under normal adhesion conditions, the evidence presented
thus far is not fully convincing for either localization. We
speculate that under normal adhesion conditions, HIC-5
senses the adhesion status based on the fact that its NES
is protected from attack by ROS in the adhesion complex
and is able to assist HIC-5 shuttling. Once the cells lapse
into a state of abnormal adhesion, such as detachment from
the matrix, the adhesion structure becomes disrupted along
with ROS production; under such conditions, NES of HIC-
5 is unmasked, becomes exposed to ROS, and is modiﬁed
to stop the shuttling. When shuttling of HIC-5 is stopped,
cell growth is arrested through the mechanisms involving
cyclin D and p21Cip1. In other words, HIC-5 organizes a
fail-safe system that ensures the anchorage dependence of
cell growth. The activation mechanism of this system is
oxidative modiﬁcation of NES of HIC-5 in response to
increased production of ROS as well as the collapse of the
focaladhesion complex. At this point, it should be noted that
the interaction between FAK and HIC-5 is also sensitive to
ROS.ThisisbecauseFAKandHIC-5interactthroughLD3of
HIC-5, which contains NES, and this interaction is regulated
by the upstream cysteines in the same manner as for NES
[32]. Therefore, the interaction between FAK and HIC-5 is6 International Journal of Cell Biology
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Figure 2: A mobile HIC-5/PINCH scaﬀold regulating cyclin D1 subcellular localization in response to adhesion status. Cyclin D1 is retained
in the nucleus in adherent cells such as mouse primary ﬁbroblasts, C3H10T1/2 ﬁbroblasts, and mammary epithelial NMuMG cells by the
CRM1-dependent nuclear export of HIC-5 with the aid of PINCH, which counteracts the nuclear export of cyclin D1. The higher aﬃnity
of HIC-5 for CRM1 favours the export of HIC-5. In detached cells, the nuclear export of HIC-5 is inhibited by elevated levels of ROS, and
cyclin D1 is actively transported out of the nucleus, which results in a decrease in its nuclear localization (see further details in [24]).
also lost under abnormal adhesion conditions, suggesting
that the functionality of NES and the complex formation of
HIC-5, at least with FAK, in the focal adhesion complex are
intimately interrelated.
In an earlier section, we discussed the role of HIC-5
at focal adhesions and on actin stress ﬁbres. Considering
that most of these results were observed in cells exposed
to stresses such as detachment and stretching but not in
cells under normal conditions, HIC-5 functions can, after
all, be interpreted as being closely related to the abnormity
of the adhesion environment and devoted to suppression of
extreme changes in the cytoskeleton as well as to prevention
of proliferation under abnormal adhesion conditions.
A group studying glomerulosclerosis has reported that
HIC-5 is signiﬁcantly induced and involved in the induction
of cell death in a pathological model, where mesangial cells
were cultured on collagen that was of a diﬀerent type to
the original extracellular matrix [33]. This observation may
have captured the essence of HIC-5’s function of sensing
abnormal adhesion status.
6.CancerCellsand HIC-5
The organization of HIC-5 as a fail-safe system for ensuring
the anchorage dependence of cell growth is expected to
be involved in the cancer development process. In this
point, it should be noted that although HIC-5 is actively
involved in the growth arrest of ﬁbroblasts via induction
of p21Cip1 on loss of anchorage, it is not involved in the
anoikis or cell death of epithelial cells (unpublished data).
This may be concerned with the fact that p21Cip1,w h i c hi s
the target of HIC-5 action and functions in growth arrest,
was not induced in normal epithelial cells under detached
conditions. Instead, epithelial cells undergo anoikis that is
governed by a group of factors specialized for cell death
execution. Given these ﬁndings together with its relatively
high expression in mesenchymal cells, HIC-5 might be an
importantmoleculeinthedevelopmentofsarcoma.Another
interesting possibility is that HIC-5 may be involved in the
epithelial-mesenchymal transition, as was pointed out by
Tumbarello and Turner [34]. The ability of HIC-5 to act as
a steroid hormone receptor coactivator has led to studies
of its involvement in prostate cancer and endometriosis.
Furthermore, a study of a human breast cancer cell line
showed that both paxillin and HIC-5 have distinct impacts
on cancer cell phenotypes related to metastatic potential.
According to this study, in which siRNA was used for
knockdown of the genes, both paxillin and HIC-5 function
inpromotingmetastaticpotentialalthoughthroughdiﬀerent
mechanisms. However, in our recent experiment usingInternational Journal of Cell Biology 7
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Figure 3: A fail-safe system where HIC-5 ensures the anchorage dependence of cell growth through LIM-LIM interactions. On loss of
adhesion, HIC-5 activates two modes of a fail-safe system in collaboration with PINCH and CRP2 to prevent anchorage-independent cell
growth. The HIC-5-PINCH unit halts its nuclear-cytoplasmic shuttling and makes way for cyclin D1 to be exported from the nucleus by
CRM1, as illustrated in Figure 2, while simultaneously transactivating p21Cip1 in the nucleus together with another HIC-5 unit, HIC-5-
CRP2. As such, the dual systems, which target cyclin D1 and p21Cip1, respectively, cooperatively stop detached cells from proliferating and
thus avoid unacceptable anchorage-independent growth (see further details in [24]).
shRNA, which would be more adequate for long-term
observation than siRNA, we found contradictory results.
These studies suggest that HIC-5 is potentially involved in
thedevelopment of certaincarcinomas.However,HIC-5 and
cellular transformation remains a controversial issue and
awaits further investigation.
In our earlier study, HIC-5 expression dropped sharply
and dramatically during immortalization of mouse ﬁbrob-
lasts [35]. In contrast, forced expression of HIC-5 induced
a senescence-like phenotype with decreased proliferative
potential after repeated passages in some immortalized
human ﬁbroblasts [36]. Recently, it was found that the
anchorage-independent growth of cancer cells over a long
period of time may be negatively regulated by HIC-5
(unpublished data). Thus, the interaction of cell adhesion
andthemortality/senescenceprocesswouldbeaninteresting
subject for future study of HIC-5 biology in association with
cancer cells.
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